+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Polymerase Chain Reaction Market by Product, Technology, Application, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 191 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5666542
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Polymerase Chain Reaction Market grew from USD 9.08 billion in 2023 to USD 10.20 billion in 2024. It is expected to continue growing at a CAGR of 12.57%, reaching USD 20.82 billion by 2030.

Polymerase Chain Reaction (PCR) is a revolutionary technique in molecular biology that allows for the amplification of DNA sequences, making it a powerful tool for various applications, primarily in medical diagnostics, forensic science, and biotechnology. The necessity of PCR arises from its ability to produce large quantities of DNA from a small initial sample, facilitating detailed genetic analysis which is essential for disease detection, genetic testing, and research. The application and end-use scope of PCR are vast, including clinical laboratories, pharmaceutical and biotechnology industries, academic institutions, and research centers. The market for PCR is influenced by the increasing demand for early disease diagnosis, advancements in PCR technologies like digital and real-time PCR, and the expanding application of PCR in emerging markets. Opportunities lie in developing more cost-effective and efficient PCR technologies, deepening market penetration in developing regions, and expanding the applicability to newer fields such as agriculture and environmental science. However, market growth is challenged by the high cost of equipment, technical complexities, and stringent regulatory requirements. These limitations necessitate a focus on innovation, like developing portable PCR devices for point-of-care testing and integrating artificial intelligence to streamline processes. Researchers and businesses can explore miniaturized PCR systems that promise faster and more accurate results and invest in PCR's digitalization to enhance data management and interpretation. Despite the competitive landscape, PCR's market nature remains adaptive, driven by continuous technological advancements and evolving healthcare needs. By addressing current limitations through sustainable, cost-effective innovations and strategic alliances, companies can leverage substantial growth potential in this crucial market segment.

Understanding Market Dynamics in the Polymerase Chain Reaction Market

The Polymerase Chain Reaction Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Rise in the prevalence of infectious diseases, cancer, and genetic disease
    • Increasing life science and biopharmaceutical research and development activities
    • Growing demand in the food & beverage industry
  • Market Restraints
    • High cost associated with a polymer chain reaction
  • Market Opportunities
    • Introduction of high sensitive and optimized polymer chain reaction instruments
    • Technological advancements in molecular biology, life sciences, and biotechnology
  • Market Challenges
    • Technical limitations of polymer chain reaction systems

Exploring Porter’s Five Forces for the Polymerase Chain Reaction Market

Porter’s Five Forces framework further strengthens the insights of the Polymerase Chain Reaction Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Polymerase Chain Reaction Market

External macro-environmental factors deeply influence the performance of the Polymerase Chain Reaction Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Polymerase Chain Reaction Market

The Polymerase Chain Reaction Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Polymerase Chain Reaction Market

The Polymerase Chain Reaction Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Polymerase Chain Reaction Market

The Polymerase Chain Reaction Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Polymerase Chain Reaction Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., 3M Company, Abbott Laboratories, ACON Laboratories, Inc., Agilent Technologies, Inc., Azure Biosystems Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMérieux, S.A., Danaher Corporation, Eppendorf SE, F. Hoffmann-La Roche Ltd., Fluidigm Corporation, GeneCopoeia, Inc., Illumina, Inc., JN Medsys Pte. Ltd., Kawasaki Heavy Industries, Ltd., KYORIN Pharmaceutical Co., Ltd., LabTurbo Biotech Corporation, LGC Limited, MBS Molecular Biology Systems, Merck KGaA, Microsynth AG, Molbio Diagnostics Pvt. Ltd., Ningbo Scientz Biotechnology Co., Ltd., Promega Corporation, Shimadzu Corporation, Siemens AG, Standard BioTools, Stilla Technologies, Stilla Technologies Inc., SV SCIENTIFIC PRIVATE LIMITED, Sysmex AG, Takara Bio Inc., Thermo Fisher Scientific, Inc., and VWR International, LLC by Avantor, Inc..

Market Segmentation & Coverage

This research report categorizes the Polymerase Chain Reaction Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Consumables & Reagents
    • Instruments
    • Software & Services
  • Technology
    • Digital PCR
    • Real-time PCR
    • Traditional PCR
  • Application
    • Medical
      • Clinical
        • Blood screening
        • Oncology testing
        • Pathology testing
      • Forensics
      • Research
    • Non-Medical
      • Agriculture
      • Food
  • End-User
    • Academic Research Institutes
    • Biotechnology Companies
    • Contract Research Organization/ Contract Manufacturing Organization
    • Diagnostic Laboratories
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rise in the prevalence of infectious diseases, cancer, and genetic disease
5.1.1.2. Increasing life science and biopharmaceutical research and development activities
5.1.1.3. Growing demand in the food & beverage industry
5.1.2. Restraints
5.1.2.1. High cost associated with a polymer chain reaction
5.1.3. Opportunities
5.1.3.1. Introduction of high sensitive and optimized polymer chain reaction instruments
5.1.3.2. Technological advancements in molecular biology, life sciences, and biotechnology
5.1.4. Challenges
5.1.4.1. Technical limitations of polymer chain reaction systems
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Polymerase Chain Reaction Market, by Product
6.1. Introduction
6.2. Consumables & Reagents
6.3. Instruments
6.4. Software & Services
7. Polymerase Chain Reaction Market, by Technology
7.1. Introduction
7.2. Digital PCR
7.3. Real-time PCR
7.4. Traditional PCR
8. Polymerase Chain Reaction Market, by Application
8.1. Introduction
8.2. Medical
8.2.1. Clinical
8.2.1.1. Blood screening
8.2.1.2. Oncology testing
8.2.1.3. Pathology testing
8.2.2. Forensics
8.2.3. Research
8.3. Non-Medical
8.3.1. Agriculture
8.3.2. Food
9. Polymerase Chain Reaction Market, by End-User
9.1. Introduction
9.2. Academic Research Institutes
9.3. Biotechnology Companies
9.4. Contract Research Organization/ Contract Manufacturing Organization
9.5. Diagnostic Laboratories
9.6. Hospitals
10. Americas Polymerase Chain Reaction Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Polymerase Chain Reaction Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Polymerase Chain Reaction Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Next Generation of qPCR Reagents push the boundaries of performance
13.3.2. Mumbai-based Rivaara Labs raises funding from Amicus, Kotak investment advisors
13.3.3. Roche introduces the cobas 5800, a new molecular diagnostic system to expand access to PCR testing in the U.S.
13.3.4. Bosch’s Vivalytic platform offering new PCR rapid test for MRSA
13.3.5. Molbio Diagnostics raises $85 mn from Temasek at unicorn valuation
13.3.6. Genomadix Inc. announces know-how license agreement with Mayo Clinic
13.3.7. GenScript launches monkeypox PCR test
13.3.8. Zymo Research to invest in Star Array for PCR platform development
13.3.9. North York life sciences company gets $2.5M from provincial fund to help produce PCR test chemicals
13.3.10. Roche expands the COVID-19 PCR test portfolio to the new cobas 5800 System in countries accepting the CE Mark
13.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. POLYMERASE CHAIN REACTION MARKET RESEARCH PROCESS
FIGURE 2. POLYMERASE CHAIN REACTION MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 9. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 13. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS POLYMERASE CHAIN REACTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS POLYMERASE CHAIN REACTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES POLYMERASE CHAIN REACTION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES POLYMERASE CHAIN REACTION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC POLYMERASE CHAIN REACTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC POLYMERASE CHAIN REACTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. POLYMERASE CHAIN REACTION MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. POLYMERASE CHAIN REACTION MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. POLYMERASE CHAIN REACTION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. POLYMERASE CHAIN REACTION MARKET DYNAMICS
TABLE 7. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY CONSUMABLES & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY TRADITIONAL PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY BLOOD SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY ONCOLOGY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY PATHOLOGY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY FORENSICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY AGRICULTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY FOOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATION/ CONTRACT MANUFACTURING ORGANIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS POLYMERASE CHAIN REACTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 48. ARGENTINA POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 57. CANADA POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 58. CANADA POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 59. CANADA POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. CANADA POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 61. CANADA POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 62. CANADA POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 63. CANADA POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 64. MEXICO POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 65. MEXICO POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 66. MEXICO POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. MEXICO POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 68. MEXICO POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 69. MEXICO POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 70. MEXICO POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES POLYMERASE CHAIN REACTION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 79. ASIA-PACIFIC POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 80. ASIA-PACIFIC POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. ASIA-PACIFIC POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 83. ASIA-PACIFIC POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 84. ASIA-PACIFIC POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 85. ASIA-PACIFIC POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 86. ASIA-PACIFIC POLYMERASE CHAIN REACTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 87. AUSTRALIA POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 88. AUSTRALIA POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 89. AUSTRALIA POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. AUSTRALIA POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 91. AUSTRALIA POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 92. AUSTRALIA POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 93. AUSTRALIA POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 94. CHINA POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 95. CHINA POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 96. CHINA POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. CHINA POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 98. CHINA POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 99. CHINA POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 100. CHINA POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 101. INDIA POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 102. INDIA POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 103. INDIA POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. INDIA POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 105. INDIA POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 106. INDIA POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 107. INDIA POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 108. INDONESIA POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 109. INDONESIA POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 110. INDONESIA POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. INDONESIA POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 112. INDONESIA POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 113. INDONESIA POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 114. INDONESIA POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. JAPAN POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 116. JAPAN POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 117. JAPAN POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. JAPAN POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 119. JAPAN POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 120. JAPAN POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 121. JAPAN POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 122. MALAYSIA POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 123. MALAYSIA POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 124. MALAYSIA POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. MALAYSIA POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 126. MALAYSIA POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 127. MALAYSIA POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 128. MALAYSIA POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 129. PHILIPPINES POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 130. PHILIPPINES POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 131. PHILIPPINES POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. PHILIPPINES POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 133. PHILIPPINES POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 134. PHILIPPINES POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 135. PHILIPPINES POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 136. SINGAPORE POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 137. SINGAPORE POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 138. SINGAPORE POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. SINGAPORE POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 140. SINGAPORE POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 141. SINGAPORE POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 142. SINGAPORE POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 143. SOUTH KOREA POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 144. SOUTH KOREA POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 145. SOUTH KOREA POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. SOUTH KOREA POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 147. SOUTH KOREA POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 148. SOUTH KOREA POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 149. SOUTH KOREA POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 150. TAIWAN POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 151. TAIWAN POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 152. TAIWAN POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. TAIWAN POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 154. TAIWAN POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 155. TAIWAN POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 156. TAIWAN POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 157. THAILAND POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 158. THAILAND POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 159. THAILAND POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. THAILAND POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 161. THAILAND POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 162. THAILAND POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 163. THAILAND POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 164. VIETNAM POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 165. VIETNAM POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 166. VIETNAM POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. VIETNAM POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 168. VIETNAM POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 169. VIETNAM POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 170. VIETNAM POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 179. DENMARK POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 180. DENMARK POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 181. DENMARK POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. DENMARK POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 183. DENMARK POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 184. DENMARK POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 185. DENMARK POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 186. EGYPT POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 187. EGYPT POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 188. EGYPT POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. EGYPT POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 190. EGYPT POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 191. EGYPT POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 192. EGYPT POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 193. FINLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 194. FINLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 195. FINLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 196. FINLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 197. FINLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 198. FINLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 199. FINLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 200. FRANCE POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 201. FRANCE POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 202. FRANCE POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 203. FRANCE POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 204. FRANCE POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 205. FRANCE POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 206. FRANCE POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 207. GERMANY POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 208. GERMANY POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 209. GERMANY POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 210. GERMANY POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 211. GERMANY POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 212. GERMANY POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 213. GERMANY POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 214. ISRAEL POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 215. ISRAEL POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 216. ISRAEL POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 217. ISRAEL POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 218. ISRAEL POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 219. ISRAEL POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 220. ISRAEL POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 221. ITALY POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 222. ITALY POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 223. ITALY POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 224. ITALY POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 225. ITALY POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 226. ITALY POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 227. ITALY POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 228. NETHERLANDS POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 229. NETHERLANDS POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 230. NETHERLANDS POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 231. NETHERLANDS POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 232. NETHERLANDS POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 233. NETHERLANDS POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 234. NETHERLANDS POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 235. NIGERIA POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 236. NIGERIA POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 237. NIGERIA POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 238. NIGERIA POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 239. NIGERIA POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 240. NIGERIA POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 241. NIGERIA POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 242. NORWAY POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 243. NORWAY POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 244. NORWAY POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 245. NORWAY POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 246. NORWAY POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 247. NORWAY POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 248. NORWAY POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 249. POLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 250. POLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 251. POLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 252. POLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 253. POLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 254. POLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 255. POLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 256. QATAR POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 257. QATAR POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 258. QATAR POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 259. QATAR POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 260. QATAR POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 261. QATAR POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 262. QATAR POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 263. RUSSIA POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 264. RUSSIA POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 265. RUSSIA POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 266. RUSSIA POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 267. RUSSIA POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 268. RUSSIA POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 269. RUSSIA POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 270. SAUDI ARABIA POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 272. SAUDI ARABIA POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 274. SAUDI ARABIA POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 276. SAUDI ARABIA POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 278. SOUTH AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 280. SOUTH AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 282. SOUTH AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 284. SPAIN POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 285. SPAIN POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 286. SPAIN POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 287. SPAIN POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 288. SPAIN POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 289. SPAIN POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 290. SPAIN POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 291. SWEDEN POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 292. SWEDEN POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 293. SWEDEN POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 294. SWEDEN POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 295. SWEDEN POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 296. SWEDEN POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 297. SWEDEN POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 298. SWITZERLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 299. SWITZERLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 300. SWITZERLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 301. SWITZERLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 302. SWITZERLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 303. SWITZERLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 304. SWITZERLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 305. TURKEY POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 306. TURKEY POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 307. TURKEY POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 308. TURKEY POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 309. TURKEY POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 310. TURKEY POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 311. TURKEY POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 312. UNITED ARAB EMIRATES POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 313. UNITED ARAB EMIRATES POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 314. UNITED ARAB EMIRATES POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 315. UNITED ARAB EMIRATES POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 316. UNITED ARAB EMIRATES POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 317. UNITED ARAB EMIRATES POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 318. UNITED ARAB EMIRATES POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 319. UNITED KINGDOM POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 320. UNITED KINGDOM POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 321. UNITED KINGDOM POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 322. UNITED KINGDOM POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 323. UNITED KINGDOM POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 324. UNITED KINGDOM POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 325. UNITED KINGDOM POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 326. POLYMERASE CHAIN REACTION MARKET SHARE, BY KEY PLAYER, 2023
TABLE 327. POLYMERASE CHAIN REACTION MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Polymerase Chain Reaction Market, which are profiled in this report, include:
  • 10x Genomics, Inc.
  • 3M Company
  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Azure Biosystems Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMérieux, S.A.
  • Danaher Corporation
  • Eppendorf SE
  • F. Hoffmann-La Roche Ltd.
  • Fluidigm Corporation
  • GeneCopoeia, Inc.
  • Illumina, Inc.
  • JN Medsys Pte. Ltd.
  • Kawasaki Heavy Industries, Ltd.
  • KYORIN Pharmaceutical Co., Ltd.
  • LabTurbo Biotech Corporation
  • LGC Limited
  • MBS Molecular Biology Systems
  • Merck KGaA
  • Microsynth AG
  • Molbio Diagnostics Pvt. Ltd.
  • Ningbo Scientz Biotechnology Co., Ltd.
  • Promega Corporation
  • Shimadzu Corporation
  • Siemens AG
  • Standard BioTools
  • Stilla Technologies
  • Stilla Technologies Inc.
  • SV SCIENTIFIC PRIVATE LIMITED
  • Sysmex AG
  • Takara Bio Inc.
  • Thermo Fisher Scientific, Inc.
  • VWR International, LLC by Avantor, Inc.

Methodology

Loading
LOADING...

Table Information